retatrutide 32 Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% This weight-loss drug hasn't been

Oprah previously said she didnt want to take medication for weight loss because she felt it was the easy way out. But eventually, she released her own shame about it and consulted her doctor, who prescribed a weight loss medication

Samms RJ, et al

Our bodies simply respond to the deficit by shedding weight, and that weight can come from both fat and muscle

GLP-1 receptor agonists work by mimicking a natural hormone that helps regulate blood sugar, control appetite, and support weight loss

If unsure if stopping or continuing is the right option, a healthcare provider may recommend a lower dose with the potential to taper off in the future

Comparing the Best Weight Loss Meds: Injectables vs